Top 10 Technologies Accelerating Drug Discovery

August 9, 2026

Eli Lilly and Novo Nordisk Compete in the Obesity Drug Industry

May 31, 2023

Eli Lilly Invests $250 Million to Strengthen Ties with Purdue University

May 13, 2025

Must Read

BMS Reports Twin Phase 3 Wins in Lung Disease And Solid Tumor

October 14, 2026

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

October 14, 2026

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

October 14, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

BMS Reports Twin Phase 3 Wins in Lung Disease And Solid Tumor

MimiVax’s brain cancer vaccine misses phase 2b goal, but CEO sees a path forward in younger patients

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Zealand’s obesity medication fails once more in phase 3

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Theramex purchases Asieris’ innovative cervical lesion treatment for up to $250 million

Novartis agrees to pay Abogen $7.8 billion for its in vivo autoimmune T-cell engager

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Top 10 AI Trends Reshaping Precision Medicine

The Economics of Rare Disease Drug Development

The Economics of Decentralized Clinical Trials

Top 10 Digital Biomarkers Changing Clinical Research

Commercial

Potentially tough road for BMS as immuno-oncology pricing war looms

Editor Picks

Top 10 Technologies Accelerating Drug Discovery

Eli Lilly and Novo Nordisk Compete in the Obesity Drug Industry

Eli Lilly Invests $250 Million to Strengthen Ties with Purdue University

Must Read

BMS Reports Twin Phase 3 Wins in Lung Disease And Solid Tumor

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Hot Topics

About Us

Follow Us